No Priors: Artificial Intelligence | Technology | Startups

AI-Powered Biological Software with Jakob Uszkoreit, CEO of Inceptive

Aug 24, 2023

35:23

Snipd AI

Jakob Uszkoreit, co-founder of Inceptive and former Google Translate and Assistant teams lead, discusses the application of deep learning in biological design, optimizing vaccine production, and more efficient drug discovery. Topics covered include the use of attention in deep learning, exploring potential architectures, challenges in AI systems, deep learning in biological research, language pre-training, and the iterative process of data generation in AI-powered biological software.

AI Summary

Highlights

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Inceptive is using deep learning to design RNA and mRNA molecules for more efficient drug production and distribution in the field of medicine.

The application of deep learning to biology enables the design of complex RNA-based medicines with personalized functions and scalability advantages for future medical interventions.

Deep dives

Inceptive's Focus on Biological Software

Inceptive, a company founded by Jakub Uskarit, aims to design better RNA and mRNA molecules for various medicines. The goal is to use deep learning models to translate biological programs into RNA molecule descriptions that can perform specific functions in the body. This approach allows for the creation of complex and scalable medicines that can be manufactured and distributed more efficiently than traditional protein-based biologics. Inceptive believes that deep learning, with its ability to work with black box systems, could revolutionize the field of biology and lead to significant advancements in medicine.

Does It Make Any Sense to Train on Generated Data?

03:08

Find us on Twitter at NoPryersPod

00:26

Introduction

4min

Exploring Transformers and the Potential for Other Architectures

22min

Exploring the Controversies and Challenges of AI and the Black Box Approach

2min

Deep Learning and its Connection to Traditional Biological Research Methods

2min

Language Pre-training, Brain Rewiring, and AGI

2min

AI-Powered Biological Software: Data Generation and Incentive

4min

"Biological Software" is the future of medicine. Jakob Uszkoreit, CEO and Co-founder of Inceptive, joins Sarah Guo and Elad Gil this week on No Priors, to discuss how deep learning is expanding the horizons of RNA and mRNA therapeutics.

Jakob co-authored the revolutionary paper Attention is All You Need while at Google, and led early Google Translate and Google Assistant teams. Now at Inceptive, he's applying these same architectures and ideas to biological design, optimizing vaccine production, and magnitude-more efficient drug discovery. We also discuss Jakob's perspective on promising research directions, and his point of view that model architectures will actually get simpler from here, and be driven by hardware.

Show Links:

Show Notes:

(0:00:00) - Creating Biological Software

(0:06:54) - The Hardware Drivers of Large-Scale Transformers

(0:14:32) - Challenges in Optimizing Compute Allocation

(0:23:25) - Deep Learning in Biology and RNA

(0:32:49) - The Future of Drug Discovery

(0:41:41) - Collaboration and Innovation at Inceptive

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

No Priors: Artificial Intelligence | Technology | Startups

AI-Powered Biological Software with Jakob Uszkoreit, CEO of Inceptive